Imipenem + Cilastatin Mevon Powder for solution for Injection 500 mg + 500 mg
Product details
Registration number: SIN14329P
Classification: Prescription Only
Active ingredients:
- Imipenem Monohydrate 530mg corresponding to Imipenem
- Sodium Cilastatin 530mg Corresponding to Cilastatin
Strength:
- 500mg
- 500mg
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Registrant: NOVEM PHARMA PRIVATE LIMITED
ATC code: J01D H51
HSA approval date: 20 March 2013
Manufacturer(s):
- ACS DOBFAR S.p.A (Filling of Drug product sterile bulk)
- ACS Dobfar SpA 2: Addetta Site (Drug product bulk)
Manufacturing country/countries: ITALY
What are the HSA registration number and classification for Imipenem + Cilastatin Mevon Powder for solution for Injection 500 mg + 500 mg?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14329P
Classification: Prescription Only
What active ingredients and strength are recorded for Imipenem + Cilastatin Mevon Powder for solution for Injection 500 mg + 500 mg?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Imipenem Monohydrate 530mg corresponding to Imipenem
- Sodium Cilastatin 530mg Corresponding to Cilastatin
Strength:
- 500mg
- 500mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Imipenem + Cilastatin Mevon Powder for solution for Injection 500 mg + 500 mg?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for Imipenem + Cilastatin Mevon Powder for solution for Injection 500 mg + 500 mg?
According to the HSA dataset updated 7 August 2026:
Registrant: NOVEM PHARMA PRIVATE LIMITED
Which manufacturers and countries are listed for Imipenem + Cilastatin Mevon Powder for solution for Injection 500 mg + 500 mg?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- ACS DOBFAR S.p.A (Filling of Drug product sterile bulk)
- ACS Dobfar SpA 2: Addetta Site (Drug product bulk)
Manufacturing country/countries: ITALY
Where can I look up Imipenem + Cilastatin Mevon Powder for solution for Injection 500 mg + 500 mg in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14329P or the exact product name Imipenem + Cilastatin Mevon Powder for solution for Injection 500 mg + 500 mg. The general register link does not preselect this product.
What are the source dates for this Imipenem + Cilastatin Mevon Powder for solution for Injection 500 mg + 500 mg record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Imipenem + Cilastatin Mevon Powder for solution for Injection 500 mg + 500 mg record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14329P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)